Fruth Investment Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-12,600
| Closed | – | – | 235 |
|
|
2021
Q1 | $0 | Hold |
12,600
| – | – | ﹤0.01% | 228 |
|
|
2020
Q4 | $31K | Sell |
12,600
-400
| -3% | -$974 | 0.01% | 210 |
|
|
2020
Q3 | $40K | Hold |
13,000
| – | – | 0.02% | 191 |
|
|
2020
Q2 | $37K | Hold |
13,000
| – | – | 0.02% | 191 |
|
|
2020
Q1 | $36K | Hold |
13,000
| – | – | 0.02% | 175 |
|
|
2019
Q4 | $42K | Hold |
13,000
| – | – | 0.02% | 201 |
|
|
2019
Q3 | $28K | Buy |
13,000
+3,000
| +30% | +$8.02K | 0.01% | 191 |
|
|
2019
Q2 | $31K | Hold |
10,000
| – | – | 0.01% | 196 |
|
|
2019
Q1 | $37K | Sell |
10,000
-300
| -3% | -$1.01K | 0.02% | 193 |
|
|
2018
Q4 | $29K | Buy |
+10,300
| New | +$28.3K | 0.01% | 183 |
|
|
2017
Q4 | – | Sell |
-10,200
| Closed | -$34K | – | 201 |
|
|
2017
Q3 | $34K | Hold |
10,200
| – | – | 0.02% | 187 |
|
|
2017
Q2 | $25K | Sell |
10,200
-100
| -1% | -$230 | 0.01% | 190 |
|
|
2017
Q1 | $23K | Hold |
10,300
| – | – | 0.01% | 193 |
|
|
2016
Q4 | $21K | Sell |
10,300
-1,000
| -9% | -$2.79K | 0.01% | 187 |
|
|
2016
Q3 | $37K | Sell |
11,300
-300
| -3% | -$952 | 0.02% | 188 |
|
|
2016
Q2 | $36K | Hold |
11,600
| – | – | 0.02% | 190 |
|
|
2016
Q1 | $38K | Sell |
11,600
-300
| -3% | -$935 | 0.02% | 182 |
|
|
2015
Q4 | $42K | Buy |
11,900
+1,000
| +9% | +$4.19K | 0.02% | 187 |
|
|
2015
Q3 | $54K | Hold |
10,900
| – | – | 0.03% | 189 |
|
|
2015
Q2 | $70K | Hold |
10,900
| – | – | 0.03% | 195 |
|
|
2015
Q1 | $76K | Hold |
10,900
| – | – | 0.03% | 219 |
|
|
2014
Q4 | $84K | Hold |
10,900
| – | – | 0.04% | 220 |
|
|
2014
Q3 | $81K | Buy |
+10,900
| New | +$101K | 0.04% | 221 |
|
|
2014
Q2 | – | Sell |
-10,150
| Closed | -$85K | – | 203 |
|
|
2014
Q1 | $85K | Sell |
10,150
-100
| -1% | -$857 | 0.04% | 195 |
|
|
2013
Q4 | $86K | Sell |
10,250
-500
| -5% | -$4.21K | 0.04% | 193 |
|
|
2013
Q3 | $85K | Sell |
10,750
-200
| -2% | -$1.61K | 0.04% | 185 |
|
|
2013
Q2 | $84K | Buy |
+10,950
| New | +$85.4K | 0.05% | 181 |
|
Other funds holding PDLI
Fruth Investment Management's PDLI Position: Q2 2021 in Review
Fruth Investment Management sold out of PDL BioPharma, Inc. (PDLI) in Q2 2021, closing a stake of 12,600 shares.
Fruth Investment Management first reported a position in PDLI in Q2 2013 and held it in 27 quarters. The position peaked at $86K in Q4 2013. 8 funds tracked by Wall St. Rank hold PDLI as of Q2 2021.
- Fruth Investment Management reported no remaining PDL BioPharma, Inc. position as of Q2 2021 after selling out during the quarter.
- Fruth Investment Management sold 12,600 PDL BioPharma, Inc. shares in Q2 2021.
- Fruth Investment Management first reported a position in PDL BioPharma, Inc. in Q2 2013 and held it in 27 quarters.
- Fruth Investment Management's PDL BioPharma, Inc. position peaked at $86K in Q4 2013.
- 8 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2021.
Based on Fruth Investment Management's 13F filing for Q2 2021, filed 19 Jul 2021.